Stonepine Capital Management as of June 30, 2020
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 13 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio | 27.1 | $14M | 2.7M | 5.10 | |
| Ligand Pharmaceuticals Com New (LGND) | 20.0 | $10M | 92k | 111.85 | |
| Cti Biopharma | 9.1 | $4.7M | 4.1M | 1.16 | |
| Diamedica Therapeutics Com New (DMAC) | 9.0 | $4.6M | 668k | 6.93 | |
| Catalyst Biosciences Com New | 6.2 | $3.2M | 548k | 5.87 | |
| Neos Therapeutics | 5.9 | $3.0M | 4.4M | 0.69 | |
| Xoma Corp Com New (XOMA) | 5.7 | $3.0M | 150k | 19.76 | |
| Apollo Endosurgery | 4.6 | $2.4M | 1.4M | 1.63 | |
| Cumberland Pharmaceuticals (CPIX) | 4.4 | $2.3M | 677k | 3.33 | |
| Adamas Pharmaceuticals | 3.8 | $1.9M | 758k | 2.56 | |
| Cerecor | 2.3 | $1.2M | 451k | 2.60 | |
| Progenity | 1.7 | $865k | 96k | 9.00 | |
| Brickell Biotech | 0.3 | $147k | 147k | 1.00 |
